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ABSTRACT
Cholesterol is an essential constituent of all mammalian cell membranes, and its availability is
therefore a prerequisite for cellular growth and other functions. Several lines of evidence are now
indicating an association between alterations of cholesterol homeostasis and cell cycle progression
in cancer cells. However, the role of cholesterol in cell differentiation is still largely unknown. To
begin to address this issue, in this study we examined changes in cholesterol metabolism and in the
mRNA levels of proteins involved in cholesterol import and esterification (multi-drug resistance,
MDR-3) and acylCoA:cholesterol acyltransferase (ACAT) and cholesterol export (caveolin-1) in
Friend virus-induced erythroleukemia cells (MELC), in the absence or in the presence of the
chemical inducer of differentiation, hexamethylene bisacetamide (HMBA). In uninduced MELC,
cholesterol synthesis, esterification and MDR-3 and ACAT mRNAs increased as cells progressed
from resting to proliferating phase, while caveolin-1 decreased. These results provide evidence that
cholesterol esterification “per se” may have a role in cell division. When MELC are treated with
HMBA, the reduction of DNA synthesis caused by the inducer is accompanied by an extensive
decrease of cholesterol esterification and of ACAT and MDR-3 mRNA levels and by a significant
increase in caveolin-1 mRNA. On the other hand, detection of cytoplasmic neutral lipids by staining
MELC with oil-ORO, a dye able to evidence CE but not FC, revealed that HMBA-treatment
inhibits cholesterol ester accumulation in MELC to approximately the same extent as the ACAT
inhibitor, SaH. These results, other than, to add new insights on the possible role of cholesterol
metabolism during tumor growth, for the first time indicate a possible involvement of cholesterol
esterification pathways in the regulating of differentiation of erythroleukemic cells.
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INTRODUCTION
Cholesterol balance in cells is a function of the amount taken up from extracellular sources, the
amount newly made by the cell, the amount stored as cholesterol esters (CE) and the amount
removed by cholesterol acceptors like high density lipoprotein (HDL). Based on the notion that
activation of cell growth imposes additional need for cellular cholesterol to support membrane
synthesis, a potential mechanism contributing to abnormal growth might involve altered cellular
sterol balance and /or metabolism. A relationship between cholesterol metabolism and tumoral
growth has been previously shown in our laboratories in different animal models of tumors 1,2 as
well as in various types of human neoplasms 3-5, including leukemias [6. A constant finding of
these studies was that tumors are characterized by specific pattern of cholesterol metabolism,
namely an increase of cholesterol synthesis and an accumulation of CE in tumoral cells, and a
corresponding decrease of HDL cholesterol in the plasma compartment. More recently, “in vitro”
studies [7-8] have provided a plausible association between cholesterol esterification and the control
of cell cycle progression, indicating that cholesterol esterification may act by accelerating signal
transduction pathways involved in cell cycle control [9]. Several “in vitro” studies have shown that
proliferation and differentiation are inversely correlated processes [10,11]. Many cancers exhibit both
loss of normal proliferation controls and a block in completing differentiation [12]. In this context,
Friend virus-induced erythroleukemia of mice give rise to permanent cell lines of transformed
erythroid/megakaryocyte precursor cells that are blocked at about the
proerythroblast/megaerythroblast stage of differentiation [14-17]. Treatment of these murine
erythroleukemia cell (MELC) lines with chemical inducers of differentiation such as
hexamethylene bisacetamide (HMBA), causes them to reinitiate erythroid differentiation
culminating in the synthesis of hemoglobin, terminal cell division, and loss of tumorigenicity [18-21].
Such cell system offer an attractive opportunity to better explore the coordination of rate of cell
proliferation and differentiation and cholesterol esterification. Therefore, we assayed the levels of
newly synthesized cholesterol (free and ester), cholesterol esterification and the rate of growth
during differentiation induced in MELC by HMBA.
Cholesterol esterification is one of the mechanisms that cells use to control the amount of toxic free
cholesterol (FC); under conditions of excess cholesterol, this is transported from the plasma
membrane to the endoplasmic reticulum (ER) where is esterified [22, 23].
Several lines of evidence are now indicating that caveolin-1, the key structural protein of caveolae
(cholesterol-rich membrane microdomains) and P-glycoprotein (P-gp), the product of the multidrug
resistance (MDR-1 in humans and the MDR-3 in rodents) gene have inverse implications in the
cholesterol metabolism of normal cells. The MDR gene is involved in the process of cholesterol
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esterification, being required for transport of FC from the plasma membrane to endoplasmic
reticulum (ER), the site of cholesterol esterification by acyl-CoA:cholesterol acyltransferase
(ACAT) [24, 25]. In contrast, caveolin-1 is required for translocation of cholesterol from the ER to the
plasma membrane and is involved in cholesterol efflux [26-28].
However, in spite of the fact that MDR and caveolin-1 are recognized as playing a major role in
intracellular cholesterol ester metabolism, it is still unclear why during tumor growth, membrane
cholesterol is preferentially shifted to the ER, leading to an accumulation of CE, rather than being
released to the appropriate extra cellular HDL acceptor. These observations prompted us to
investigate levels of ACAT-1, MDR-3, and caveolin-1 mRNAs during differentiation of MELC
induced by HMBA.
MATERIALS AND METHODS
Cell cultures, conditions for induction, and reagents
MELCs (derived from the 745/A strain) were grown in suspension using RPMI 1640 medium (Bio-
Whittaker Europe, Verviers, Belgium) containing 2 mM glutamine and supplemented with 5% fetal
bovine serum (FBS) Boehringer-Mannheim, Mannheim, Germany) at 37°C in a 5% CO2-
humidified atmosphere. Cells were usually seeded at a density of 105 cells/ml and passaged every 4-
5 days. Induction of MELC differentiation was carried out by supplementing cultures with 5 mM
HMBA (Sigma, St. Louis, MO).
At the start of the experiments, cells from the stock cultures were diluted and seeded at a density of
l x 105 cells/ml in 10% FBS. Unless otherwise indicated, cells were harvested at 0, 24, 48, 72, and
96 h after seeding.
Analysis of cellular growth
At the times indicated, cells supplemented with 10% FBS were washed with PBS, harvested with
trypsin/EDTA (0.05%/0.02%) and cell number was counted using a Coulter counter. For the
thymidine incorporation studies, cells were labelled with 3H-thymidine at 5Ci/ml during the last 3
hours of incubation, and radioactivity incorporated into the DNA was determined by trichloroacetic
acid precipitation of the cell lysate. Protein content was determined by Lowry et al.[29].
Cholesterol Biosynthesis and Esterification
To assess cholesterol biosynthesis, cells were incubated in medium containing 10% of FBS with
(14C)acetate (final radioactivity of 7.4 MBq/ml) for 4 hours at 37 °C in a CO2 incubator. To assess
cholesterol esterification, cells were incubated for 4 h at 37 °C with (14C)oleic acid (specific activity
of 2.22 GBq/mmol, final radioactivity of 0.185 MBq/ml; Amersham Biosciences) complex with
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BSA [essentially fatty acid-free; Sigma). Cells were washed, and lipids were extracted and analyzed
by thin layer chromatography (TLC) as described previously [9]. Spots of cholesterol and cholesteryl
oleate were identified by standards (Sigma), scraped, and counted in a β-counter. 
RNA extraction, reverse transcription (RT)-PCR analysis
Total RNA was isolated from cells using the guanidine isothiocyanate phenol-chloroform extraction
method [30]. RNA yield was quantified spectrophotometrically and A260/A280 ratios determined.
The integrity and accuracy of the spectrophotometric measurement of each RNA sample was
assessed by electrophoresis of 1 μg on an ethidium bromide-stained, agarose minigel. Equal 
amounts of total RNA (0.5 g) were reverse transcribed into cDNA using oligo dT. cDNA was
subsequently amplified by the polymerase chain reaction (PCR) in the presence of specific primers
according to the instructions provided by the manufacturer (GeneAmp RNA PCR Kit, Perkin-Elmer
Cetus). The PCR was performed using the following primers and conditions: for MDR-3,
5’CATCAGCCCTGTTCTTGGACT3’, 5’GAGATGTTGGCCGTGATAGCT3 ’(234-bp fragment);
94°C for 30 seconds, 58°C for 60 seconds, and 72°C for 60 seconds for 30 cycles. For ACAT-1,
5’TGCCTGAGCTACTTCTACCCA3’, 5’CACGTAACGACAAGTCCAGGT3’ (266-bp
fragment); 95°C for 30 seconds, 60°C for 30 seconds, and 72°C for 40 seconds, for 30 cycles. For
caveolin-1, 5’CTACAAGCCCAACAACAAGGC 3’, 5’AGGAAGCTCTTGATGCACGGT 3’ (340
bp fragment); 965°C for 25 seconds, 58°C for 30 seconds, and 73°C for 50 seconds, for 30 cycles.
For -actin, 5’GCCTCTGGTCGTACCACTGGC3’, 5’AGGGAGGAAGAGGATGCGGCA3’ (278
bp fragment); 95°C for 30 seconds, 59°C for 30 seconds, and 72°C for 45 seconds, for 30 cycles.
Preliminary experiments demonstrated that using these PCR conditions the amount of product
amplification to RNA relationship was linear for the cycle number used over the range 500-1500 ng
of total RNA. Working in these conditions PCR products separated on agarose and stained with
ethidium bromide were characterized by a major band of the predicted size (data not shown).
Blotting analysis
During PCR reaction the nonradioactive label Digoxigenin-11-dUTP (DIG; Boheringer Mannheim)
was incorporated and immunodetected with anti-digoxigenin Fab fragments conjugated to alkaline
phosphatase and visualized with the chemiluminescence substrate CSPD®. Enzymatic
dephosphorylation of CSPD® by alkaline phosphatase led to a light emission at a maximum
wavelength of 477 nm which was recorded on X-ray films. The DNA fragments were separated by
electrophoresis on agaroseand then blotted onto a nylon membrane for 16 h in 10XSSC. The blot
was exposed to X-ray film for 2-10 minutes. A Kodak Digital Science Band Scanner Image
Analysis System containing HP ScanJet, ID Image Analysis Software assessed the intensity of the
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bands in the autoradiograms. The overall procedure was standardized by expressing the amount of
PCR product for each target mRNA relative to the amount of product formed for -actin. Since a
low yield of PCR products is often obtained when cDNA segments are coamplified with an internal
standard gene in the same tube, the relative levels of gene expression were determined by
comparing the PCR products of the target cDNA and -actin gene processed in separate tubes.
Microscopic Analysis
For microscopic analysis, MELC, grown in suspension as described above, were treated with 5 mM
HMBA or with 4 M of the acyl amide ACAT inhibitor SaH 58-035 (SaH) kindly provided by
Novartis Pharma AG, Basel, Switzerland and harvested after 72 h. To visualize the degree of
cytoplasmic neutral lipid (NL) accumulation, MELC were washed three times with PBS, and fixed
by soaking in 10% formalin. Cells were then treated with isopropyl alcohol (60%), washed, and
stained with oil red O (ORO) (a lipid-soluble dye which stains NL, including CE, but not FC) and
then counterstained with Mayer’s hematoxylin NL appear as bright red spots in the cytoplasm. Cells
were imaged using a Leitz inverted-phase microscope fitted with a digital camera.
Statistical analysis
Data were reported as the average values ±SE. Student’s t-test, suitably computed by means of the
grouped data method, was used, and a probability value of p < 0.05 was regarded as statistically
significant.
RESULTS
Inhibition of cell growth of MELC by HMBA
When the rate of cell proliferation was analyzed, about 65% fewer cells were found in HMBA-
induced cultures compared to uninduced after 3 days of culturing, when the cultures were
approaching confluence (p < 0.05) (Fig. 1A). Similarly, the rate of 3H-thymidine incorporation was
consistently higher in MELC than in HMBA-treated cells (Fig. 1B). The increased ability to growth
in MELC compared with HMBA-cells was also reflected in a higher content of proteins in the
former compared with the latter (Fig. 1C).
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Figure 1. Time course of cell growth,
MELC in presence or absence of HMBA.
and stimulated to growth by adding 10% FCS. At the indicated times, cell number (A),
thymidine incorporation (B) and protein content (C) were determined as described in Materials and
Methods. Data are mean  SE of three independent experiments, each performed in triplicate.
*indicates statistically significant (p
3H-thymidine incorporation and protein content in
MELC cells were seeded at a density of 1x10
< 0.05) compared with MELC .
5 cells/ml
3H-
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
10
.5
15
5.
1 
: P
os
te
d 
31
 O
ct
 2
01
0
Inhibition of cholesterol esterification in MELC by HMBA
Cholesterol biosynthesis and esterification in MELC and HMBA-MELC were assessed as an
indirect measure of changes in intracellular cholesterol content. The rate of (14C)acetate
incorporation into FC in control cells was almost twice that in HMBA cells (p < 0.05) (Fig. 2A).
When the rate of (14C)acetate incorporation into CE was assessed (Fig. 2B), a 2-to 10-fold lower CE
synthesis was observed in HMBA cells. Accordingly, the rate of (14C)oleic acid incorporation into
CE in HMBA cells was at least 60% lower compared with that in uninduced MELC cells (p < 0.05)
(Fig. 2C).
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Figure 2. Time course of 14 C-
incorporation into CE (C) of MELC in presence or absence of HMBA
cultured as in Fig. 1. 14 C-acetate and
harvested every 24 h for a total period of 96 h. Data are mean
experiments, each performed in triplicate. *indicat
with MELC.
acetate incorporated into FC (A) and EC (B) and
14C-oleate were added 3 h before each time point. MELC were
 SE of three independent
es statistically significant (p<0.05) compared
14C-oleate
. MELC cells were
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PCR analysis in MELC and HMB
To further evaluate the possibility
determining cell growth and differentiation, we next
expression of some genes implicated in the regulation of intracellular cholesterol trafficking:
ACAT-1 and MDR-3, involved in the import of cholesterol, and caveolin
detection of ACAT-1, MDR-3 and caveolin
transcripts, and analyses have revealed the occurrence of PCR products migrating at positions
consistent with the expected size of
MELCs were found to express relatively high levels of ACAT
significantly decreased during MELC induction to terminal division by 5 mM HMBA
A and B). By contrast, caveolin
augmented in HMBA-induced cells (Fig. 3 and Fig.
Figure 3. MDR-1, ACAT-1 and Caveolin
MELC. The figure shows representative autoradiograms of MDR
1) and β-actin mRNA in MELC and in HMBA treated MELC. RT
as described in Materials and Methods.
A-cells
that cholesterol esterification “per se” may be a limiting factor in
evaluated in MELC and HMBA
-
-1 mRNAs has been carried out by PCR on reverse
266 bp, 234-bp, 340 bp, respectively (data not shown). Growing
-1 and MDR
-1 gene expression, powerfully suppressed in gr
4C).
-1 mRNA levels in MELC and HMBA
-1, ACAT
- PCR analysis was performed
-cells, the
1, in the export. The
-3 mRNAs, which
, (Fig. 3 and 4
owing MELC,
-induced
-1, caveolin-1 (Cav-
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Figure 4. Relative levels of ACAT
RT-PCR analysis was performed for three independent
(A), MDR-3 (B) and Caveolin
actin levels and expressed as percentage.
-1, MDR-3 and Caveolin-1 (C) mRNA in MELC.
experiments. Relative levels of ACAT
-1 (Cav-1) (C) mRNA were normalized to the corresponding β
-1
-
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Microscopic Analysis
Finally, to examine the effects of pharmacological inhibition of cholesterol esterification on cell
growth and differentiation, we compared the effects of HMBA with those of SaH 58-035 (SaH), a
specific inhibitor of ACAT, especially with regard to morphologic and neutral lipid changes on
MELC cultures. The results showed that, MELC, 72 h after SaH-treatment, are smaller and have
smaller nuclei compared to untreated cells, in that resembling the 72 h HMBA-treated cells (Fig.
5A). On the other hand, detection of cytoplasmic neutral lipids by staining MELC with ORO, a dye
able to evidence CE but not FC, revealed that HMBA-treatment inhibits cholesterol ester
accumulation in MELC to approximately the same extent as the ACAT inhibitor, SaH.
Figure 5 Photographs of MELC cultures with or without treatment with HMBA and SaH. A:
microphotographs taken by using an inverted microscopy of untreated or HMBA and SaH treated-
MELC 72 h after culture. B: microphotograpfs of the above cell cultures examined by inverted
microscopy stained with ORO for neutral lipids and counter-stained with hematoxylin for nuclei.
DISCUSSION
This study attempts to evaluate a possible role of cholesterol esterification in the regulation of cell
growth and differentiation. To do this, we utilized MELC as a model of cell differentiation by using
either uninduced or HMBA-induced cultures as actively proliferating or differentiating cell
populations, respectively. It was found that cholesterol esterification is (i) enhanced during active
DNA synthesis and (ii) inhibited concomitantly with pharmacologically-induced cell differentiation
A
B
MELC MELC + HMBA MELC + SaHN
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and growth arrest. Particularly, the rate of cholesterol esterification seems to parallel cellular
replication and, actually, precedes the onset of DNA synthesis. Intracellular cholesterol transport
are now receiving increasing attention as devices that cholesterol in specialized membrane platform
called rafts could have a role in the regulation of a number of signal transduction pathways,
including those involved in cell division and differentiation [31]. Studies with cholesterol-depleted
cells demonstrated that a reduced level of cholesterol in the rafts is by itself a signal to activate
pathway leading to cell division [32,33]. ACAT-1, MDR-3 and caveolin-1 are a part of the lipid
transport system that counterbalances excessive intracellular cholesterol. It has been suggested that
MDR-3 transports excess cholesterol from the plasma membrane to ER where it is esterified by
ACAT [24,25]. On the contrary, caveolin-1 transports cholesterol from ER to plasma membrane
where it become the preferential source of cholesterol for efflux [27, 28]. As an essential component of
caveolae, caveolin-1 is also involved in numerous signalling pathways [32-34]. Involvement of these
proteins in cholesterol trafficking makes them potential targets to improve our knowledge on the
possible role of cholesterol esterification in stimulation of growth and differentiation. In this work,
we demonstrate that down-regulation of ACAT-1 and MDR-3 and up-regulation of caveolin-1 in
MELC are strictly correlated with cell differentiation induced by HMBA. These findings raise the
possibility that MDR-3 and caveolin-1, might specifically influence raft-dependent signal
transduction, at least in part, so reinforcing the possibility that cholesterol esterification, MDR-1,
caveolin-1 and signal transduction may be closely linked. The view is consistent with the induction
of MDR-3- and ACAT-1 and with the reduction of caveolin-1 mRNA in MELC cell growing, and
with the opposite pattern observed in differentiating cells. Further studies are necessary to provide a
complete mechanistic understanding of exactly how cholesterol esterification regulates cell
differentiation, however, we could reach a tentative hypothesis: when cells are stimulated to divide,
such as during tumorigenesis, the intracellular cholesterol increases, however it beside to be
transported and distributed within the plasma membranes in lipid rafts, accumulate in the cytoplasm
as CE. The consequent lower levels of FC into the rafts, by actively enhancing the integrated
interchange of signaling molecules involved in cell division, such as Ras-MAPK cascade, may
contribute to accelerate tumor progression [35]. Conversely, when cells are stimulated to
differentiation, the inhibition of cholesterol esterification, by increasing the expression of caveolin-
1 and possibly FC content into the rafts, may lead to a reduction of signal transduction activation
[32,33,35]. Proliferating tumor cells, could be then reprogrammed to terminal division toward the
mature phenotype with consequent loss of tumorigenicity.
In summary, the results of this study, other than to add new insights on the possible role of
cholesterol metabolism during tumor growth, for the first time indicate a possible involvement of
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cholesterol esterification pathways in the regulating of differentiation of erythroleukemic cells.
These findings are also of interest for the concept of using cholesterol esterification and related
proteins as possible pharmacological targets for modulation of cell growth and/or differentiation.
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